Skip to content

Amgen AMGN Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Pfizer logo
PfizerPFE
5.7B+0.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
107.7M-3.1%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
24.7M+75.9%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
19.7M+8.3%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
66.1M+8.4%

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$190.42B+22.4%
Enterprise value$247.18B+16.4%
P/E24.4×-1.8×
P/S5.1×+0.6×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's shares (diluted)?
Amgen (AMGN) reported shares (diluted) of 544M in Q1 2026.
How has Amgen's shares (diluted) changed year-over-year?
Amgen's shares (diluted) increased by 0.6% year-over-year, from 541M to 544M.
What is the long-term trend for Amgen's shares (diluted)?
Over 4 years (2021 to 2025), Amgen's shares (diluted) has grown at a -1.5% compound annual growth rate (CAGR), from 2.3B to 2.2B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.